Table 2.
Total contents of knee society score, visual analog scale and range of motion in three groups
| Variable | Mean±SD | P * | P** (between multimodal injection and placebo) | P** (between multimodal injection and control group) | P** (between placebo group and control group) | ||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Multimodal injection | Placebo group | Control group | |||||
| KSS | |||||||
| Baseline | 1.49±24.894 | 1.94±23.942 | 6.84±13.801 | 0.39 | 0.918 | 0.224 | 0.26 |
| Within 6 weeks | 113.15±14.89 | 100.24±17.97 | 102.02±7.91 | <0.001 | <0.001 | <0.001 | 0.53 |
| Within 6 months | 115.96±13.49 | 101.20±16.62 | 98.53±6.97 | <0.001 | <0.001 | <0.001 | 0.31 |
| P1 (time) | <0.001 | <0.001 | <0.001 | ||||
| P3 (intervention) | 0.001 | ||||||
| VAS | |||||||
| Baseline | 7±1.22 | 7.39±1.07 | 7.27±1.09 | 0.24 | 0.098 | 0.25 | 0.59 |
| Within 24 h | 6.39±1.45 | 8.80±0.88 | 8.10±0.65 | <0.001 | <0.001 | <0.001 | 0.001 |
| Within 48 h | 5.02±1.25 | 6.20±1.22 | 6.18±0.80 | <0.001 | <0.001 | <0.001 | 0.92 |
| Within 6 weeks | 3.46±1.14 | 4.15±1.25 | 3.67±0.65 | 0.006 | 0.002 | 0.31 | 0.028 |
| P1 (time) | <0.001 | <0.001 | <0.001 | ||||
| P3 (intervention) | <0.001 | ||||||
| ROM | |||||||
| Baseline | 87.89±10.41 | 90.10±10.02 | 90±3.68 | 0.37 | 0.21 | 0.23 | 0.95 |
| Within 24 h | 107.56±6.36 | 94.49±3.57 | 95±2.88 | <0.001 | <0.001 | <0.001 | 0.57 |
| Within 48 h | 113.44±5.09 | 96.12±4.11 | 98.16±2.83 | <0.001 | <0.001 | <0.001 | 0.015 |
| Within 6 weeks | 128.33±13.18 | 119.80±8.16 | 122.65±4.57 | <0.001 | <0.001 | 0.003 | 0.12 |
| P1 (time) | <0.001 | <0.001 | <0.001 | ||||
| P3 (intervention) | <0.001 | ||||||
*ANOVA, **Post hoc Tukey test. P1, P2, P3 at the 5% level error of repeated measures. KSS=Knee society score; VAS=Visual Analogue Scale; ROM=Range of motion; SD=Standard deviation